Diabetic Neuropathy
📧 Sign up to get email alerts when something new happens for Diabetic Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: High Diagnostic Performance of the Indicator Plaster Neuropad for the Detection of Diabetic Autonomic Neuropathy
Clinical trial update showing that Neuropad, an indicator plaster, demonstrated high diagnostic performance for detecting diabetic autonomic…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Effect of Reiki on Neuropathic Pain Severity and Sleep Quality in Patients With Diabetic Neuropathy [NA]
A clinical trial is evaluating whether Reiki can reduce neuropathic pain severity and improve sleep quality in people with diabetic neuropat…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Posterior Tibial Nerve PRF for Diabetic Neuropathic Pain [NA]
Completed clinical trial evaluating posterior tibial nerve pulsed radiofrequency for painful diabetic neuropathy.
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Foot Reflexology in Diabetic Patients With Neuropathic Pain [NA]
A completed clinical trial evaluated foot reflexology as an intervention for neuropathic pain in patients with diabetes.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy. [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating nebivolol as a disease-modifying treatment for diabetic neuropathy and is currently recruitin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Gremlin-1 and Wagner Classification: Potential Biomarker for Amputation in Diabetic Foot Patients
A completed clinical trial evaluated Gremlin-1 and Wagner Classification as potential biomarkers to predict amputation risk in patients with…
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Effect of Exercise Therapy on Type II Diabetic Neuropathic Patients [NA]
Clinical trial update indicates completion of a study evaluating the effects of exercise therapy in adults with Type 2 diabetes and neuropat…
-
FDA approval · 2024-12-27FDA Approved: GABAPENTIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for gabapentin from Rising Pharma Holdings, Inc. The snippet does not specify the exact scope (e.g.,…
-
EMA approval · 2024-11-29EMA Authorised: Duloxetine Zentiva (duloxetine) — Zentiva, k.s.
The EMA authorised Duloxetine Zentiva (duloxetine) from Zentiva, k.s. as an approved medicinal product for neuralgia/diabetic neuropathy, ma…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Dose-finding Study: Popliteal Sciatic Nerve Block in Patients Undergoing Diabetic Foot Surgery [NA]
A dose-finding study of popliteal sciatic nerve block for diabetic foot surgery is being conducted; the trial status is active but not recru…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Role of Synchronized Lifestyle Modification Program on Diabetic Neuropathy Taking Oral Hypoglycemics [NA]
A completed clinical trial update evaluating a synchronized lifestyle modification program for individuals with diabetic neuropathy who are …
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: MultiSENSory Stimulation to TArgeT Sensory Loss and ChronIc Pain in NeurOpathic PatieNts [NA]
ETH Zurich is recruiting for a trial to test multi-sensory stimulation to address sensory loss and chronic neuropathic pain in patients with…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Digital Heath Integration With Neuromodulation Therapies on Diabetic Neuropathy [NA]
This ClinicalTrials.gov entry reports a recruiting study from Cairo University exploring digital health integration with neuromodulation the…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects [Phase 1]
Phase 1 trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of oral AJH-2947 in healthy adult male subjects (K…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Effects of Modified Otago Versus Action Observation on Strength, Mobility and Fall Risk in Diabetic Neuropathy [NA]
The completed trial compared Modified Otago training with Action Observation to assess effects on strength, mobility, and fall risk in indiv…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Effect of Educational Booklet for Foot-related Exercises for Prevention and Treatment in People With Diabetic Neuropathy [NA]
This clinical trial evaluated an educational booklet on foot-related exercises for preventing and treating diabetic neuropathy; the study ha…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Surface Electromyography Study of Fatigue in Diabetic Neuropathy [NA]
A clinical trial update notes that the surface electromyography study of fatigue in diabetic neuropathy has completed.
-
FDA approval · 2024-09-09FDA Approved: GABAPENTIN — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for gabapentin from Rising Pharma Holdings, Inc. The approval indicates a modification to the dr…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Differences In The Severity Of Diabetic Neuropathy Based On Electromyography In Type 2 Diabetes Mellitus Patients With And Without Comorbidities
A completed clinical trial comparing the severity of diabetic neuropathy in type 2 diabetes patients with and without comorbidities using el…
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With Neuropathy [Phase 2]
A Phase 2 trial evaluating an antioxidant therapy's effect on oxidative stress biomarkers in adults with type 2 diabetes and peripheral diab…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes
A completed clinical trial comparing histamine and local heating methods to evoke the axon-reflex flare response in people with diabetes, in…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Hyperbaric Oxygen Therapy in Diabetic Foot
A clinical trial evaluating hyperbaric oxygen therapy for diabetic foot conditions has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Short-term Effect of Podiatric Callus Debridement on Plantar Pressure in Diabetic Neuropathic Patients [NA]
A completed clinical trial examined whether podiatric callus debridement affects plantar pressure in patients with diabetic neuropathy.
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) [NA]
Abbott Medical Devices is conducting a clinical trial (XANADO) to evaluate external sensing and neuromodulation for diabetic pain outcomes; …
-
EMA approval · 2024-07-09EMA Authorised: Cymbalta (duloxetine) — Eli Lilly Nederland B.V.
Cymbalta (duloxetine) has been authorized by the EMA for anxiety disorders, diabetic neuropathy, and major depressive disorder with Eli Lill…